D-0257-2025 Class II Terminated
FDA drug recall D-0257-2025 was initiated by Nephron Sterile Compounding Center LLC on Feb 10, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port. The recall status is terminated (terminated Aug 14, 2025). Affected quantity: 4,190 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 19, 2025
- Initiation Date
- Feb 10, 2025
- Termination Date
- Aug 14, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,190 bottles
Product description
Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West Columbia, SC 29172, NDC: 69374-334-50
Reason for recall
Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.
Distribution pattern
US Nationwide.
Code information
Lot # NA4008B, exp. date 03/03/2025 Lot # NA4005B & NA4005E, exp. date 02/20/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0257-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026